Episode
Breast Cancer — 5-Minute Journal Club Issue 4 with Dr Kevin Kalinsky: Defining the Role of TROP2-Directed Antibody-Drug Conjugates
- Podcast
- Breast Cancer Update
- Published
- Oct 27, 2025
- Duration seconds
- 940
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/breast-cancer-update-757579/episodes/breast-cancer-5-minute-journal-club-issue-4-with-dr-kevin-kalinsky-defining-the-role-of-trop2-directed-antibody-drug-conjugates/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/breast-cancer-update-757579/breast-cancer-5-minute-journal-club-issue-4-with-dr-kevin-kalinsky-defining-the-role-of-trop2-directed-antibody-drug-conjugates.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Kevin Kalinsky from Winship Cancer Institute of Emory University in Atlanta, Georgia, discusses recent developments with TROP2-directed antibody-drug conjugates in the management of breast cancer. CME information and select publications here .